NIH: million-person precision medicine study 'a constant learning process'

By Melissa Fassbender contact

- Last updated on GMT

Volunteers will contribute a range of health, environment, and lifestyle information using a variety of platforms. (Image: iStock/jm1366)
Volunteers will contribute a range of health, environment, and lifestyle information using a variety of platforms. (Image: iStock/jm1366)

Related tags: Health care, Health care provider

The Precision Medicine Initiative (PMI) Cohort Program is expected to launch later this year with the goal of enrolling more than one million US participants by 2020.

As part of the study, PMI volunteers will contribute a range of health, environment, and lifestyle information through blood and urine tests as well as electronic health records.

While the study won’t focus on a specific disease, researchers hope to gain a better understanding of several important health questions. The breadth of the study will allow researchers to create a platform to enable trials of targeted therapies, gain a better understanding of pharmacogenomics and the use of mobile health​, among others.

There are many aspects of the program that will require thoughtful planning and implementation—from participant engagement​ to data security and plenty of other things in between​,” Joni Rutter, Ph.D., Director of the Division of Programs and Strategic Implementation, with the PMI Cohort Program, NIH, told us.

With its unprecedented study size, Rutter explained that the NIH plans “to approach this as a constant learning process, refining our approaches and iterating as we go.​”

One already defined approach will be to use mobile health devices and applications to allow participants to provide data in real time​ – a ubiquitous trend​ in clinical studies as of late.

Volunteers will be able to enroll directly through Participant Technologies Centers​ – who will develop, test, and maintain the program’s mobile applications – or through one of many health care provider organizations (HPO).

Guiding all of our efforts are a set of core values, including the commitments to involve our participants as partners and to make data broadly accessible for research purposes​,” said Rutter.

Rutter added that the NIH is planning a national campaign to raise awareness about the PMI Cohort Program and the opportunity for participants to join the research effort.

The campaign will include media outreach and collaborations with local and national organizations, among other strategies to ensure that our participants reflect America’s rich diversity​,” said Rutter.

Additionally, the program’s HPO partners will promote enrollment​ opportunities to their patients in the health care setting. The immediate next step is to establish governance for the program.

We’ll be setting up an executive committee, steering committee, and working groups to develop more detailed plans for the program in anticipation of the national launch later this year​,” explained Rutter.

Then we’ll work to stand up the biobank and Participant Technologies Center (PTC); have our health care provider organizations work together with the PTC to finalize the protocol; conduct data transfer tests with the Data and Research Support Center; and begin initial outreach activities to raise awareness of the program, among other activities​,” she said.

The Data and Research Support Center has been awarded to Vanderbilt University Medical Center, working with the Broad Institute, and Verily Life Sciences​. The center will acquire, organize, and provide secure access to the dataset, which, according to NIH, “will be one of the world’s largest and most diverse datasets for precision medicine research​.”

The center will also provide research support and analysis tools to a range of researchers from across the industry who will be able to propose further studies using the information gathered during the PMI Cohort Program.

For more information, visit www.nih.gov/precision-medicine-initiative-cohort-program​.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars